Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A vocal cord injection for adductor spasmodic dysphonia
ChiCTR1900025865Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of botulinum toxin type A in laryngeal dystonia (SD) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Laryngoscope findings, Voice Handicap Index score and 1 more. Planned start Sep 2019; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
laryngeal dystonia (SD)
Beyond the preview
Go deeper on ChiCTR1900025865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025865.